PIERRE, S.D. (AP) -- Attorney General Marty Jackley says South Dakota will get more than $1 million as its share of a national settlement with a pharmaceutical manufacturer that allegedly distributed substandard drugs.
Jackley says South Dakota joined with other states and the federal government in a $500 million dollar settlement to resolve allegations involving Ranbaxy, a company based in Gurgaon, India. He says the company allegedly manufactured, distributed and sold generic drugs whose strength, purity or quality fell below federal standards.
South Dakota's portion of the settlement is more than $1.1 million. Jackley says more than $761,000 will be kept by the federal government as the federal Medicaid share. The remaining $408,000 will go to the state general fund to offset alleged damages to the state's share of the Medicaid program's cost.